Zinger Key Points
- Holley faces macroeconomic challenges, with softer sales outlook despite 20% EBITDA margin target for 2025.
- Analyst forecasts 2% organic decline in Q1 sales, with full-year sales down 2%, but 2.5% organic growth expected.
- Feel unsure about the market’s next move? Copy trade alerts from Matt Maley—a Wall Street veteran who consistently finds profits in volatile markets. Claim your 7-Day free trial now.
J.P. Morgan analyst Christian Carlino reiterated the Neutral rating on Holley Inc. HLLY.
Carlino has expressed concerns over a lack of catalysts for growth and the ongoing macroeconomic challenges affecting the company.
While the 2025 guidance suggests that Holley could achieve its target of a 20% EBITDA margin, the analyst notes that the overall sentiment may be impacted by a “softer” top-line outlook.
The valuation is strongest at the top of the income statement, but the softer revenue projections are likely to drive sentiment, given the current consumer environment, analyst writes.
According to Carlino, Holley’s market share performance in the fourth quarter is impacted by distribution partners reducing safety stock due to the company’s enhanced supply chain capabilities.
On a positive note, direct-to-consumer sales grew by 8% in the fourth quarter, helped by improved marketing efforts, and sales through national retailers increased by 12% due to expanded SKU offerings and retailers consolidating purchases with more reliable suppliers.
Holley’s sales guidance for the year is weighted toward the second half, with softer consumer confidence and weather pressures affecting the first quarter.
The analyst is forecasting first-quarter sales of $144 million, a 2% organic decline, and total sales for the year at $590 million, down 2% year-over-year, with organic growth at 2.5%.
Price Action: HLLY shares are trading higher by 0.61% to $2.485 at last check Thursday.
Read Next:
Photo by Ground Picture on Shutterstock.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.